Opioid-Related Disorders: all 1,439 studies
Page 12 of 15. Open to participants first (291), then studies with results posted, then the rest; newest registration first within each.
- Pilot Study of Contingency Management for Smoking CessationCompletedNCT03015597Not applicable
- Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid AbstinenceCompletedNCT03015246Phase 1/2
- Single Ascending Dose Study of RBP-6000CompletedNCT03002961Phase 1
- Impact of Different Educational Approaches on Post-operative Opiate Utilization After Elective Lower Extremity SurgeryCompletedNCT02997644Not applicable
- Administration of Acetazolamide to Prevent Remifentanil Induced HyperalgesiaCompletedNCT02992938Phase 4
- Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted PatientsCompletedNCT02969668
- MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)CompletedNCT02942199Not applicable
- Harnessing Placebo Effects in Methadone TreatmentCompletedNCT02941809Not applicable
- Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or StimulantsTerminatedNCT02935101Phase 2
- Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy PrescribersCompletedNCT02926482Not applicable
- Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator ProductsStatus unknownNCT02925806
- Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid AnalgesicsStatus unknownNCT02920775
- Evaluation of Changes in Prescribing Behavior of ER/LA Opioid PrescribersStatus unknownNCT02920762
- BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3TerminatedNCT02902835Not applicable
- ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner DatabasesStatus unknownNCT02897414
- Probuphine Innovations for Clinical Effectiveness (PRINCE)Status unknownNCT02896660Not applicable
- Substance Dependence Satisfaction With Care and Quality Of LifeStatus unknownNCT02894476
- Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment CentersStatus unknownNCT02871232
- Long-acting Naltrexone for Pre-release PrisonersCompletedNCT02867124Phase 3
- ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and PoisoningStatus unknownNCT02866266
- Impact of Pregnancy on Buprenorphine Pharmacokinetics and PharmacodynamicsCompletedNCT02863601
- Screening in Trauma for Opioid Misuse PreventionCompletedNCT02861976
- Opioid Analgesic Use and Disposal Following Outpatient Dental SurgeryCompletedNCT02814305Not applicable
- Program for Pain & Prescription Opioid Use in PregnancyCompletedNCT02804152Not applicable
- Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose ReductionCompletedNCT02801357Phase 1
- Conflict Between Maternal Autonomy and Child Health in Substance-useCompletedNCT02797990
- MySafeRx™: An Integrated Mobile Platform for Buprenorphine AdherenceCompletedNCT02778282Not applicable
- Single-dose, Study of RBP-6000 in Opioid Dependent IndividualsCompletedNCT02765867Phase 1
- A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic PainCompletedNCT02751762
- Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy VolunteersCompletedNCT02750748Phase 1
- Computer-based Prescription Opioid Abuse Prevention for AdolescentsCompletedNCT02737696Not applicable
- Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer StudyStatus unknownNCT02733822Phase 1
- A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid DependenceCompletedNCT02718352
- Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealthCompletedNCT02712034Not applicable
- Comparative Evaluation of PUSPENs and C&CsTerminatedNCT02698098
- NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical StudyWithdrawnNCT02692157Phase 1/2
- A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse QuestionnaireCompletedNCT02678507
- Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or AddictionCompletedNCT02668549
- An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims DataCompletedNCT02667262
- Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec ReviewCompletedNCT02667210
- Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1BCompletedNCT02667197
- A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or DiversionCompletedNCT02667158
- Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid MedicationCompletedNCT02660619
- A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse QuestionnaireCompletedNCT02660606
- Immediate Postpartum Nexplanon Placement in Opioid Dependent WomenCompletedNCT02657148
- The Mobile Monitoring of Vital Signs in Opioid UsersWithdrawnNCT02647073Not applicable
- Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid DependenceCompletedNCT02602795Not applicable
- Mindfulness-Oriented Recovery Enhancement For Chronic Pain and Prescription Opioid Misuse in Primary CareCompletedNCT02602535Not applicable
- Navigation Services to Avoid Rehospitalization (NavSTAR)CompletedNCT02599818Not applicable
- Medication-Assisted Treatment for Youth With Substance Use DisordersCompletedNCT02593474Phase 1
- Project BEST: Buprenorphine Entry Into Substance Abuse TreatmentCompletedNCT02583243
- Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy VolunteersCompletedNCT02572089Phase 1
- Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort StudyCompletedNCT02571400
- Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use DisorderCompletedNCT02559973Phase 1
- The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent SubjectsWithdrawnNCT02516436Phase 3
- Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use DisorderCompletedNCT02502175Phase 3
- Buprenorphine and Substance Abuse Services for Prescription Opioid DependenceCompletedNCT02496403Not applicable
- Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy VolunteersCompletedNCT02477267Phase 1
- Expanded HIV Care in Opioid Substitution Treatment (EHOST) TrialCompletedNCT02440256Not applicable
- The Effectiveness of Deep Brain Stimulation for Opioid Relapse PreventionStatus unknownNCT02440152Phase 2/3
- Intervention of HIV, Drug Use and the Criminal Justice System in MalaysiaCompletedNCT02396979Phase 4
- Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal PainCompletedNCT02372591Phase 1
- The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid AntagonismCompletedNCT02362256Not applicable
- Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment AccessCompletedNCT02360007Phase 1/2
- On-site Evaluation of Substances Consumption on Opiate MaintenanceCompletedNCT02345655Not applicable
- RESPECT-PLUS: Services for Infants With Prenatal Opiate ExposureCompletedNCT02334111Not applicable
- Biomarkers of Injectable Extended Release Naltrexone TreatmentCompletedNCT02324725Phase 4
- Phone Interview to Prevent Recurring Opioid OverdosesCompletedNCT02282306Not applicable
- PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid AddictionStatus unknownNCT02282072Early Phase 1
- Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine SurgeryTerminatedNCT02276911Phase 2
- Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic PainCompletedNCT02272829Not applicable
- Pupil Response in Patients on Opioids.CompletedNCT02247024
- Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement TherapyCompletedNCT02243670Not applicable
- Desvenlafaxine in Opioid-Dependent PatientsCompletedNCT02200406Phase 4
- Sex and Female EmpowermentCompletedNCT02197715Not applicable
- Study of Integrating Antiretroviral Therapy With Methadone Treatment for People Who Inject DrugsStatus unknownNCT02167425
- Safety and Health Intervention ProjectCompletedNCT02152397Not applicable
- Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment ProgramCompletedNCT02120612
- Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone RecipientsCompletedNCT02093559Not applicable
- Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate DependenceStatus unknownNCT02052258Phase 1
- Opiate Craving Reduction Study Using Post-detox Patients on Suboxone and Use of TEAS as Adjunctive TreatmentWithdrawnNCT02033746Not applicable
- Cocaine Opioid Oxytocin Option - LimitedCompletedNCT02028533Phase 1
- Using mHealth to Aid Opioid Medication Adherence Pilot StudyCompletedNCT02017041
- Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid DependenceCompletedNCT01940588
- Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol AddictionStatus unknownNCT01934751Not applicable
- Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone MaintenanceCompletedNCT01913418Phase 2
- Transforming Opioid Prescribing in Primary CareCompletedNCT01909076Not applicable
- Cell Phone Technology Targeting ART Adherence and Drug UseCompletedNCT01884233Not applicable
- Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release NaltrexoneCompletedNCT01882361Phase 2/3
- Study of Opioid Immunosuppressive EffectsStatus unknownNCT01881802
- Trial of Methadone Maintenance Versus Methadone Detox in JailStatus unknownNCT01874964Not applicable
- Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in MalaysiaCompletedNCT01863251Phase 2
- A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine AbuseCompletedNCT01846481Phase 2
- Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained PatientsCompletedNCT01820442Phase 1
- Remote Observed Dosing to Increase Suboxone ComplianceCompletedNCT01779973Not applicable
- Pilot Test of a Community-based Buprenorphine Treatment InterventionCompletedNCT01761110Not applicable
- Neurocognitive Effects of Opiate Agonist TreatmentCompletedNCT01733693Phase 4
- Methadone Oxytocin OptionCompletedNCT01728909Early Phase 1
- Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel)CompletedNCT01718964Phase 2
- Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in NorwayCompletedNCT01717963Phase 3